

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 8.76229814 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.92331029 |
| 3 | drug catabolic process (GO:0042737) | 7.75223297 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 7.21786498 |
| 5 | regulation of fibrinolysis (GO:0051917) | 6.77486953 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 6.69111050 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 6.66901920 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.66901920 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 6.58998069 |
| 10 | complement activation, alternative pathway (GO:0006957) | 6.27632152 |
| 11 | regulation of protein activation cascade (GO:2000257) | 6.05149494 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.92881847 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 5.92881847 |
| 14 | urea metabolic process (GO:0019627) | 5.81414978 |
| 15 | cellular glucuronidation (GO:0052695) | 5.74039249 |
| 16 | uronic acid metabolic process (GO:0006063) | 5.72022707 |
| 17 | glucuronate metabolic process (GO:0019585) | 5.72022707 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 5.66414761 |
| 19 | regulation of complement activation (GO:0030449) | 5.51884613 |
| 20 | fibrinolysis (GO:0042730) | 5.39610060 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 5.37909809 |
| 22 | oxidative demethylation (GO:0070989) | 5.37149869 |
| 23 | drug metabolic process (GO:0017144) | 5.33529117 |
| 24 | phenylpropanoid metabolic process (GO:0009698) | 5.27607489 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 5.10063103 |
| 26 | glycine metabolic process (GO:0006544) | 5.08243148 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 5.07431598 |
| 28 | urea cycle (GO:0000050) | 4.94688932 |
| 29 | bile acid biosynthetic process (GO:0006699) | 4.86160005 |
| 30 | protein carboxylation (GO:0018214) | 4.86095445 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.86095445 |
| 32 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.84061666 |
| 33 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.84061666 |
| 34 | blood coagulation, intrinsic pathway (GO:0007597) | 4.80522161 |
| 35 | bile acid metabolic process (GO:0008206) | 4.65199330 |
| 36 | ethanol oxidation (GO:0006069) | 4.51213972 |
| 37 | tryptophan metabolic process (GO:0006568) | 4.49508043 |
| 38 | bile acid and bile salt transport (GO:0015721) | 4.47754602 |
| 39 | daunorubicin metabolic process (GO:0044597) | 4.42645758 |
| 40 | polyketide metabolic process (GO:0030638) | 4.42645758 |
| 41 | doxorubicin metabolic process (GO:0044598) | 4.42645758 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.40235012 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.40235012 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.39819042 |
| 45 | regulation of plasminogen activation (GO:0010755) | 4.32928116 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.19293190 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.19293190 |
| 48 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.16435495 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.13886976 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.13886976 |
| 51 | hormone catabolic process (GO:0042447) | 4.10920782 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 4.08014659 |
| 53 | serine family amino acid metabolic process (GO:0009069) | 3.99997440 |
| 54 | S-adenosylmethionine metabolic process (GO:0046500) | 3.96643841 |
| 55 | alkaloid metabolic process (GO:0009820) | 3.95069241 |
| 56 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.94068294 |
| 57 | protein activation cascade (GO:0072376) | 3.91034507 |
| 58 | regulation of cholesterol esterification (GO:0010872) | 3.79130231 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 3.75486859 |
| 60 | negative regulation of coagulation (GO:0050819) | 3.75070733 |
| 61 | acute-phase response (GO:0006953) | 3.75025138 |
| 62 | indole-containing compound catabolic process (GO:0042436) | 3.70650821 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 3.70650821 |
| 64 | tryptophan catabolic process (GO:0006569) | 3.70650821 |
| 65 | complement activation (GO:0006956) | 3.70634159 |
| 66 | negative regulation of wound healing (GO:0061045) | 3.63751712 |
| 67 | phospholipid efflux (GO:0033700) | 3.63217054 |
| 68 | aldehyde catabolic process (GO:0046185) | 3.59737479 |
| 69 | dopamine transport (GO:0015872) | 3.58859395 |
| 70 | ethanol metabolic process (GO:0006067) | 3.57191277 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 3.55057111 |
| 72 | complement activation, classical pathway (GO:0006958) | 3.54465240 |
| 73 | regulation of humoral immune response (GO:0002920) | 3.51985315 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.49720780 |
| 75 | negative regulation of protein activation cascade (GO:2000258) | 3.47423746 |
| 76 | macromolecular complex remodeling (GO:0034367) | 3.46486970 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.46486970 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 3.46486970 |
| 79 | alpha-amino acid catabolic process (GO:1901606) | 3.46274829 |
| 80 | regulation of lipoprotein particle clearance (GO:0010984) | 3.46093013 |
| 81 | opsonization (GO:0008228) | 3.31455503 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 3.31062756 |
| 83 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.30582204 |
| 84 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.30582204 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.30470120 |
| 86 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.26028217 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 3.25728301 |
| 88 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.22468953 |
| 89 | steroid catabolic process (GO:0006706) | 3.22433319 |
| 90 | xenobiotic metabolic process (GO:0006805) | 3.21283398 |
| 91 | high-density lipoprotein particle remodeling (GO:0034375) | 3.20812819 |
| 92 | drug transmembrane transport (GO:0006855) | 3.17769056 |
| 93 | positive regulation of hemostasis (GO:1900048) | 3.17646696 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 3.17646696 |
| 95 | cytolysis (GO:0019835) | 3.17417946 |
| 96 | arginine metabolic process (GO:0006525) | 3.16288576 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.14804272 |
| 98 | cellular amino acid catabolic process (GO:0009063) | 3.13454870 |
| 99 | ketone body metabolic process (GO:1902224) | 3.13121427 |
| 100 | indolalkylamine metabolic process (GO:0006586) | 3.08609550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.78508065 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.07802959 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.81635329 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.99765015 |
| 5 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.67460624 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.50860254 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.35745162 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.17652406 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.12991278 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.76658730 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74242718 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.64860246 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.61282475 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17437727 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.17205158 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89854625 |
| 17 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.89314868 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80723262 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75420906 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.65308611 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.62592000 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.58580711 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48842185 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47712551 |
| 25 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41725286 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33793969 |
| 27 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.31694270 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30647562 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23454988 |
| 30 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.23059274 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20027164 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16647671 |
| 33 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16202445 |
| 34 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14554492 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13931627 |
| 36 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.13160125 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11328275 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10506763 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09875377 |
| 40 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.09764993 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.08766273 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07654576 |
| 43 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.07403144 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05982130 |
| 45 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05432490 |
| 46 | P300_27268052_Chip-Seq_Bcells_Human | 1.04623158 |
| 47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03512560 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02352273 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.99956818 |
| 50 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99638228 |
| 51 | CBP_21632823_ChIP-Seq_H3396_Human | 0.97147886 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96603162 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94829027 |
| 54 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94125611 |
| 55 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92839394 |
| 56 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89472249 |
| 57 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89065984 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.86275560 |
| 59 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85304986 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84147154 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84107467 |
| 62 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.83971666 |
| 63 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.83971666 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83523475 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82264488 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 0.80939531 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80720910 |
| 68 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.80501782 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80403789 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80256331 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79258041 |
| 72 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.78428014 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.77320540 |
| 74 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.77260971 |
| 75 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.77165305 |
| 76 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.76563113 |
| 77 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76214386 |
| 78 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76109277 |
| 79 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.76103626 |
| 80 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.75071182 |
| 81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.74724701 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74197412 |
| 83 | ERA_21632823_ChIP-Seq_H3396_Human | 0.73014607 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72825291 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72825291 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 0.71860900 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.71611296 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.71611296 |
| 89 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70186928 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.69126761 |
| 91 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.68593004 |
| 92 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.68296638 |
| 93 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.67787256 |
| 94 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.67087936 |
| 95 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.66933034 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.66320614 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.66142211 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66070578 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.66019926 |
| 100 | NCOR_22424771_ChIP-Seq_293T_Human | 0.64937662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.66884802 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.00971928 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 4.79604879 |
| 4 | MP0005360_urolithiasis | 4.75425987 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.72269619 |
| 6 | MP0005365_abnormal_bile_salt | 4.54273276 |
| 7 | MP0003195_calcinosis | 4.04139455 |
| 8 | MP0003252_abnormal_bile_duct | 3.75109762 |
| 9 | MP0009697_abnormal_copulation | 3.65756767 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.60700911 |
| 11 | MP0003868_abnormal_feces_composition | 3.13566429 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.81107335 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.75035913 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.22916334 |
| 15 | MP0002822_catalepsy | 2.11695035 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.10584929 |
| 17 | MP0000372_irregular_coat_pigmentation | 1.81270244 |
| 18 | MP0001764_abnormal_homeostasis | 1.77984415 |
| 19 | MP0005332_abnormal_amino_acid | 1.77103898 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.76569289 |
| 21 | MP0008872_abnormal_physiological_respon | 1.59381661 |
| 22 | MP0000609_abnormal_liver_physiology | 1.53287334 |
| 23 | MP0005451_abnormal_body_composition | 1.53145678 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.43380784 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.38522930 |
| 26 | MP0005408_hypopigmentation | 1.36306268 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.35321408 |
| 28 | MP0009840_abnormal_foam_cell | 1.33840743 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.29523502 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.29260260 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.27962516 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.27962516 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.25644459 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.19860137 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.14458622 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13075435 |
| 37 | MP0005187_abnormal_penis_morphology | 1.11498340 |
| 38 | MP0009278_abnormal_bone_marrow | 1.09134816 |
| 39 | MP0005266_abnormal_metabolism | 1.05196675 |
| 40 | MP0002132_abnormal_respiratory_system | 1.04856529 |
| 41 | MP0001835_abnormal_antigen_presentation | 1.02519735 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.01698516 |
| 43 | MP0008469_abnormal_protein_level | 1.01437707 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.00513389 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.97212946 |
| 46 | MP0003186_abnormal_redox_activity | 0.94408670 |
| 47 | MP0009764_decreased_sensitivity_to | 0.93332826 |
| 48 | MP0000598_abnormal_liver_morphology | 0.92173924 |
| 49 | MP0009785_altered_susceptibility_to | 0.86775414 |
| 50 | MP0008058_abnormal_DNA_repair | 0.86021688 |
| 51 | MP0002396_abnormal_hematopoietic_system | 0.85160968 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 0.83433553 |
| 53 | MP0002735_abnormal_chemical_nociception | 0.82591282 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.81721161 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 0.79322889 |
| 56 | MP0001800_abnormal_humoral_immune | 0.77477547 |
| 57 | MP0009763_increased_sensitivity_to | 0.77400182 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 0.76346744 |
| 59 | MP0000604_amyloidosis | 0.73001938 |
| 60 | MP0005670_abnormal_white_adipose | 0.71901011 |
| 61 | MP0001661_extended_life_span | 0.70843990 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.70380196 |
| 63 | MP0003724_increased_susceptibility_to | 0.68567895 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.67616059 |
| 65 | MP0010094_abnormal_chromosome_stability | 0.65421272 |
| 66 | MP0002928_abnormal_bile_duct | 0.62951843 |
| 67 | MP0008873_increased_physiological_sensi | 0.62648295 |
| 68 | MP0001790_abnormal_immune_system | 0.62569379 |
| 69 | MP0005387_immune_system_phenotype | 0.62569379 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.62456764 |
| 71 | MP0002419_abnormal_innate_immunity | 0.62087101 |
| 72 | MP0003959_abnormal_lean_body | 0.59172967 |
| 73 | MP0005025_abnormal_response_to | 0.58706240 |
| 74 | MP0004147_increased_porphyrin_level | 0.58041748 |
| 75 | MP0002452_abnormal_antigen_presenting | 0.57670125 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.57604479 |
| 77 | MP0002723_abnormal_immune_serum | 0.57574161 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.55871059 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.55210526 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.54685137 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.54591623 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.53796617 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.51957624 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.51879172 |
| 85 | MP0004043_abnormal_pH_regulation | 0.51823329 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.51362393 |
| 87 | MP0002282_abnormal_trachea_morphology | 0.51177831 |
| 88 | MP0001915_intracranial_hemorrhage | 0.50215239 |
| 89 | MP0005535_abnormal_body_temperature | 0.48807033 |
| 90 | MP0003718_maternal_effect | 0.48603949 |
| 91 | MP0005171_absent_coat_pigmentation | 0.48507445 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.48232104 |
| 93 | MP0002971_abnormal_brown_adipose | 0.47982633 |
| 94 | MP0002420_abnormal_adaptive_immunity | 0.47270738 |
| 95 | MP0001819_abnormal_immune_cell | 0.46522962 |
| 96 | MP0005395_other_phenotype | 0.45966532 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.45655201 |
| 98 | MP0001881_abnormal_mammary_gland | 0.45282440 |
| 99 | MP0008874_decreased_physiological_sensi | 0.44205624 |
| 100 | MP0000716_abnormal_immune_system | 0.43165568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.37900802 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.65048361 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 6.52943403 |
| 4 | Complement deficiency (HP:0004431) | 6.52001988 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.16601524 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.15873203 |
| 7 | Abnormality of complement system (HP:0005339) | 4.94220534 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 4.92303210 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.70607868 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.56514606 |
| 11 | Joint hemorrhage (HP:0005261) | 4.33528501 |
| 12 | Agammaglobulinemia (HP:0004432) | 4.31570359 |
| 13 | B lymphocytopenia (HP:0010976) | 4.29274194 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.11055808 |
| 15 | Abnormality of B cell number (HP:0010975) | 4.00698236 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.96928653 |
| 17 | Spontaneous abortion (HP:0005268) | 3.76035000 |
| 18 | Severe combined immunodeficiency (HP:0004430) | 3.71164936 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59994787 |
| 20 | Thyroiditis (HP:0100646) | 3.53764124 |
| 21 | Glomerulonephritis (HP:0000099) | 3.44061099 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 3.42290328 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.31167265 |
| 24 | Hyperammonemia (HP:0001987) | 3.19470809 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.16562004 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.16057726 |
| 27 | Xanthomatosis (HP:0000991) | 3.14689028 |
| 28 | Hyperglycinemia (HP:0002154) | 3.04999675 |
| 29 | Fat malabsorption (HP:0002630) | 2.96151230 |
| 30 | Gingival bleeding (HP:0000225) | 2.85239110 |
| 31 | Combined immunodeficiency (HP:0005387) | 2.84463420 |
| 32 | Hyperglycinuria (HP:0003108) | 2.83923918 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 2.76289383 |
| 34 | Hypoplasia of the thymus (HP:0000778) | 2.74575116 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.73673066 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.70675362 |
| 37 | Dicarboxylic aciduria (HP:0003215) | 2.70646572 |
| 38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70646572 |
| 39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.67177586 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.63760221 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.63760221 |
| 42 | Cerebral palsy (HP:0100021) | 2.59452994 |
| 43 | Abnormal gallbladder physiology (HP:0012438) | 2.55673947 |
| 44 | Cholecystitis (HP:0001082) | 2.55673947 |
| 45 | Abnormality of lateral ventricle (HP:0030047) | 2.52527961 |
| 46 | Granulocytopenia (HP:0001913) | 2.50522443 |
| 47 | Nephritis (HP:0000123) | 2.49117457 |
| 48 | Steatorrhea (HP:0002570) | 2.47824084 |
| 49 | Metabolic acidosis (HP:0001942) | 2.46395286 |
| 50 | Ketosis (HP:0001946) | 2.46091954 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.41418453 |
| 52 | Eosinophilia (HP:0001880) | 2.31456858 |
| 53 | Meningitis (HP:0001287) | 2.31361167 |
| 54 | Recurrent pneumonia (HP:0006532) | 2.29671216 |
| 55 | Thrombophlebitis (HP:0004418) | 2.29036121 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.26513811 |
| 57 | Spastic paraparesis (HP:0002313) | 2.25627571 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.23464385 |
| 59 | Purpura (HP:0000979) | 2.16619825 |
| 60 | Pulmonary embolism (HP:0002204) | 2.14687846 |
| 61 | Abnormality of methionine metabolism (HP:0010901) | 2.09774142 |
| 62 | Cholelithiasis (HP:0001081) | 2.06925924 |
| 63 | Hypoalphalipoproteinemia (HP:0003233) | 2.03481410 |
| 64 | Hypoproteinemia (HP:0003075) | 2.02227453 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02181742 |
| 66 | Hepatic necrosis (HP:0002605) | 1.99269937 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 1.99144239 |
| 68 | Rickets (HP:0002748) | 1.96103187 |
| 69 | Abnormality of serum amino acid levels (HP:0003112) | 1.96100092 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 1.95053534 |
| 71 | Abnormal pupillary function (HP:0007686) | 1.92808187 |
| 72 | Hepatocellular necrosis (HP:0001404) | 1.92579421 |
| 73 | Beaking of vertebral bodies (HP:0004568) | 1.92332358 |
| 74 | Hyperbilirubinemia (HP:0002904) | 1.92036832 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 1.90538993 |
| 76 | Opisthotonus (HP:0002179) | 1.90499371 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 1.90180885 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.90180885 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.90180885 |
| 80 | Cerebral edema (HP:0002181) | 1.88696153 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 1.88488881 |
| 82 | Verrucae (HP:0200043) | 1.87187114 |
| 83 | Papilloma (HP:0012740) | 1.87187114 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85955422 |
| 85 | Abnormality of eosinophils (HP:0001879) | 1.85460160 |
| 86 | Increased serum ferritin (HP:0003281) | 1.84801404 |
| 87 | Bile duct proliferation (HP:0001408) | 1.84488503 |
| 88 | Abnormal biliary tract physiology (HP:0012439) | 1.84488503 |
| 89 | Epidermoid cyst (HP:0200040) | 1.81327042 |
| 90 | Gangrene (HP:0100758) | 1.81240570 |
| 91 | Abnormality of the prostate (HP:0008775) | 1.80448316 |
| 92 | Skin rash (HP:0000988) | 1.79629603 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79266192 |
| 94 | Death in childhood (HP:0003819) | 1.78595982 |
| 95 | Hemorrhage of the eye (HP:0011885) | 1.76426462 |
| 96 | Epistaxis (HP:0000421) | 1.75369364 |
| 97 | Glycosuria (HP:0003076) | 1.73745811 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 1.73745811 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72805553 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 1.70685509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.53084178 |
| 2 | BCKDK | 4.41272731 |
| 3 | VRK2 | 4.10681708 |
| 4 | KIT | 4.10545709 |
| 5 | TESK2 | 3.22113437 |
| 6 | ERN1 | 2.91328920 |
| 7 | FRK | 2.62761704 |
| 8 | MAP3K11 | 2.61331609 |
| 9 | NUAK1 | 2.47777474 |
| 10 | GRK6 | 2.37158981 |
| 11 | PIK3CG | 2.36530640 |
| 12 | SCYL2 | 2.17030278 |
| 13 | STK16 | 2.15951605 |
| 14 | FLT3 | 2.06641428 |
| 15 | TAF1 | 1.89601414 |
| 16 | MAP3K12 | 1.79274937 |
| 17 | KDR | 1.72897288 |
| 18 | SYK | 1.62901967 |
| 19 | BLK | 1.61633036 |
| 20 | MAP4K2 | 1.54499568 |
| 21 | MAP4K1 | 1.53818424 |
| 22 | EIF2AK1 | 1.47946193 |
| 23 | INSRR | 1.40584805 |
| 24 | TYK2 | 1.35913132 |
| 25 | CSF1R | 1.33098603 |
| 26 | CSNK1G3 | 1.24421557 |
| 27 | TXK | 1.23698468 |
| 28 | RPS6KB2 | 1.21901151 |
| 29 | ABL2 | 1.18144286 |
| 30 | PIK3CA | 1.08503837 |
| 31 | VRK1 | 1.07975422 |
| 32 | CSNK1A1L | 1.07958924 |
| 33 | MAP2K3 | 1.07554582 |
| 34 | GRK5 | 1.06117308 |
| 35 | MAPK11 | 1.02890682 |
| 36 | DAPK1 | 1.01799989 |
| 37 | RAF1 | 0.94942435 |
| 38 | MAP3K3 | 0.94228485 |
| 39 | TBK1 | 0.92379502 |
| 40 | SRPK1 | 0.91880815 |
| 41 | CSNK1G1 | 0.90332250 |
| 42 | BTK | 0.90132969 |
| 43 | CAMKK2 | 0.89455925 |
| 44 | TEC | 0.89004084 |
| 45 | EIF2AK3 | 0.88170375 |
| 46 | DYRK3 | 0.85646328 |
| 47 | MAP3K1 | 0.83352640 |
| 48 | MAP2K7 | 0.82996846 |
| 49 | MAP3K13 | 0.82478434 |
| 50 | CSNK1G2 | 0.81908043 |
| 51 | ATR | 0.74612776 |
| 52 | MAPK12 | 0.74437983 |
| 53 | LYN | 0.73507451 |
| 54 | MAPK13 | 0.72930002 |
| 55 | IRAK1 | 0.69185814 |
| 56 | PIM1 | 0.69129966 |
| 57 | MAPKAPK5 | 0.67999829 |
| 58 | PLK4 | 0.67040623 |
| 59 | BMPR1B | 0.65514324 |
| 60 | FES | 0.65393269 |
| 61 | CDK9 | 0.63678016 |
| 62 | TNK2 | 0.63664344 |
| 63 | MAP3K5 | 0.63270125 |
| 64 | CDK8 | 0.63006207 |
| 65 | CCNB1 | 0.62164197 |
| 66 | TLK1 | 0.60843033 |
| 67 | PIM2 | 0.57623544 |
| 68 | IGF1R | 0.57512386 |
| 69 | TAOK2 | 0.56081696 |
| 70 | SMG1 | 0.56046209 |
| 71 | DAPK2 | 0.50926499 |
| 72 | ZAK | 0.48929136 |
| 73 | IRAK2 | 0.48519550 |
| 74 | PRKAA2 | 0.46761410 |
| 75 | MAPKAPK3 | 0.46104434 |
| 76 | LCK | 0.44523017 |
| 77 | PDK2 | 0.43153364 |
| 78 | IKBKE | 0.42929879 |
| 79 | PINK1 | 0.41337922 |
| 80 | GRK1 | 0.40837562 |
| 81 | PRKACG | 0.39095800 |
| 82 | BRSK2 | 0.38671759 |
| 83 | ARAF | 0.35301508 |
| 84 | JAK3 | 0.35172236 |
| 85 | PLK2 | 0.33555836 |
| 86 | CSNK1D | 0.31998571 |
| 87 | TESK1 | 0.30983085 |
| 88 | IRAK4 | 0.30799082 |
| 89 | AKT2 | 0.29359552 |
| 90 | MAP2K4 | 0.29151492 |
| 91 | EIF2AK2 | 0.29008699 |
| 92 | PDK1 | 0.27723704 |
| 93 | DAPK3 | 0.25091347 |
| 94 | LRRK2 | 0.24212700 |
| 95 | HCK | 0.23308422 |
| 96 | PRKACA | 0.22946600 |
| 97 | CSNK2A2 | 0.22047654 |
| 98 | BRSK1 | 0.21380317 |
| 99 | MAPK4 | 0.20792468 |
| 100 | CSNK1A1 | 0.19102084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.40103657 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48105354 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29496942 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.18620773 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.14499011 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.12615254 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05139721 |
| 8 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 3.02937509 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.98956218 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.78591483 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.74397868 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.73706232 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.73370714 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48359235 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.36804465 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22105890 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.17168191 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11935243 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10118553 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.08623626 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.02358363 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.89201507 |
| 23 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.87488633 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.78792395 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.60794639 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51723115 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.42503622 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41331361 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39424814 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35249149 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29620794 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25601941 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23714661 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23662985 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20847871 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19670275 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17632102 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.17628940 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17491050 |
| 40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09805531 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08579342 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07291065 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07283264 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01891791 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00974353 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96596071 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86032135 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83956421 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78697510 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72161493 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72101734 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68521013 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.66109360 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62814779 |
| 55 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59106789 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58756033 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55306289 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.52928568 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52624321 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.52294512 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51395711 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.50225106 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48178310 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47803797 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46981224 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45339399 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.40990453 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 0.36138995 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33990806 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.32815154 |
| 71 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32636794 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28999142 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28674366 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25336545 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.20721002 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.20023498 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.19023670 |
| 78 | RNA polymerase_Homo sapiens_hsa03020 | 0.18562612 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.16285729 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.14819997 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.13451573 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12851151 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12736673 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.11520007 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11434984 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.09103582 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.08910266 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.05463335 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03396109 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.00452965 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1019868 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0797838 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | -0.0695570 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0507243 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.0438927 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | -0.0364164 |
| 97 | Asthma_Homo sapiens_hsa05310 | -0.0361775 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0318587 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0244328 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0095851 |

